Brave Asset Management Inc Oncolytics Biotech Inc Transaction History
Brave Asset Management Inc
- $313 Million
- Q4 2024
A detailed history of Brave Asset Management Inc transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Brave Asset Management Inc holds 25,000 shares of ONCY stock, worth $17,750. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,000
-0.0%
Holding current value
$17,750
Previous $21,000
9.52%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ONCY
# of Institutions
46Shares Held
1.3MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL200KShares$142,2840.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$134,8580.05% of portfolio
-
Goldman Sachs Group Inc New York, NY101KShares$71,9920.0% of portfolio
-
Virtu Financial LLC New York, NY98.5KShares$69,9000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$47,5260.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $41.1M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...